keith murphy

Featured

Cellink-Organovo Lawsuit Over Bioprinting Patents is Far From Over

In the highly competitive biotechnology and pharmaceutical industries, hardware manufacturers are under a lot of pressure to provide the best, most efficient, and fastest platforms for researchers. Bioprinting, in particular,…

Featured

AMS 2021: Deconstructing the Timeline to Bioprinted Organs

Automation, healthcare, metal additive manufacturing (AM), and bioprinting were the four big topics discussed at the 2021 Additive Manufacturing Strategies (AMS) summit. The two-day virtual event gathered experts for panel…

Featured

Organovo’s Keith Murphy Back as Executive Chairman

Founder and former CEO of Organovo, Keith Murphy, is back as the company’s newly appointed Executive Chairman of the Board. The news comes three years after Murphy left the pioneering…

Viscient Biosciences is Leveraging 3D Bioprinting for Drug Discovery

Biotechnology companies are uncovering new methods to develop drugs across a range of therapeutic areas. Looking to demonstrate a commitment to drug discovery and moving away from traditional laboratory animal…

Keith Murphy: “We Believe We are Discovering the Next Step in Drug Development”

It’s been three years since Keith Murphy and Jeffrey Miner joined forces to create the biotechnology company Viscient Biosciences. In 2017, the co-founders had recently left their previous successful enterprises…

Organovo’s Merger Deal with Tarveda Falls Through, for Now

It has been a stormy few months for the early-stage medical laboratory and research company Organovo. Since announcing a merger deal with Tarveda Therapeutics, a privately-held clinical-stage biopharmaceutical firm, last…

Former CEO of Organovo Urges Stockholders Against Merger with Tarveda

Gaining a competitive advantage is at the core of most businesses. That is why the financial world has a section dedicated exclusively to study the behind-the-scenes of mergers and acquisitions…

More 3D Printing Executive Transitions as Organovo CEO Keith Murphy Steps Down, to be Replaced by Taylor J. Crouch

This year has been a tumultuous one in the 3D printing industry so far. January saw the resignation of MakerBot CEO Jonathan Jaglom, who was replaced by Nadav Goshen, and…

Paul Gallant Takes GM Slot With 3D Bioprinting Innovators Organovo

Organovo Holdings, Inc. has made waves with their ability to deliver scientific and medical breakthroughs via 3D bioprinting technology. The company’s 3D bioprinting methods enable the automated creation of living…

Organovo Only 4-6 Years Away From 3D Printing Partial Livers For Human Implantation

There are so many areas within the 3D printing space one can get excited about; however, in my opinion one of the most exciting areas is the work being done…

Shock & Awe: Inside 3D Printing Conf. in Santa Clara Provides Incredible Insight, News, Rumors & More

The Inside 3D Printing Conference and Expo is known worldwide as the place to be if you or your company has any interest in the up-and-coming technology of additive manufacturing…